It is noteworthy that, percentages of CD19+/CD38hi/CD24hi/CD10+/IL-10+ were lower in ELTGF (≅50%) and in CGD patients (≅66%) versus controls (P ≤ 0.03; Figure 3(n), Table 2). This evidence concerns the gene CD19 and chronic granulomatous disease.